Skip to Content

IL 3638 (Theophylline extended-release 125 mg)

Pill imprint IL 3638 has been identified as Theophylline extended-release 125 mg.

Theophylline is used in the treatment of asthma, maintenance; asthma, acute; apnea of prematurity and belongs to the drug class methylxanthines. Risk cannot be ruled out during pregnancy. Theophylline 125 mg is not a controlled substance under the Controlled Substance Act (CSA).

Theophylline extended-release 125 mg IL 3638
Theophylline extended-release 125 mg IL 3638
Discount Card Promo
Theophylline extended-release
Imprint:
IL 3638
Strength:
125 mg
Color:
Clear
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Methylxanthines
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Inwood Laboratories Inc.
National Drug Code (NDC):
00258-3638
Inactive Ingredients:
ferric oxide black
butylparaben
castor oil
edetate calcium disodium
ethylcellulose
gelatin
methylparaben
pharmaceutical glaze
povidone
propylparaben
sodium lauryl sulfate
sodium propionate
starch
sugar spheres
magnesium silicate

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide